Supernus Pharmaceuticals
SUPN
SUPN
312 hedge funds and large institutions have $2.34B invested in Supernus Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 106 increasing their positions, 115 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
312
Holders Change
+15
Holders Change %
+5.05%
% of All Funds
7.16%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.11%
New
56
Increased
106
Reduced
115
Closed
36
Calls
$5.1M
Puts
$7.53M
Net Calls
-$2.43M
Net Calls Change
-$111K
Top Buyers
1 |
PIM
Provident Investment Management
Novi,
Michigan
|
+$24.7M |
2 |
CRCP
Copper Rock Capital Partners
Boston,
Massachusetts
|
+$24.4M |
3 |
![]()
JPMorgan Chase & Co
New York
|
+$13.2M |
4 |
Renaissance Technologies
New York
|
+$12.7M |
5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.3M |